Glucagon-Like Peptide-1 (GLP-1): Effect on Kidney Hemodynamics and Renin-Angiotensin-Aldosterone System in Healthy Men-Reference-Cited by-同舟云学术

Glucagon-Like Peptide-1 (GLP-1): Effect on Kidney Hemodynamics and Renin-Angiotensin-Aldosterone System in Healthy Men

Published:2013-04-01 Issue:4 Volume:98 Page:E664-E671
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Skov Jeppe¹²,Dejgaard Anders²,Frøkiær Jørgen³,Holst Jens Juul⁴,Jonassen Thomas⁵,Rittig Søren⁶,Christiansen Jens Sandahl¹

Affiliation:

1. Department of Endocrinology and Internal Medicine (J.S., J.S.C.), DK-8000 Aarhus, Denmark

2. Novo Nordisk A/S (J.S., A.D.), DK-2880 Bagsvaerd, Denmark

3. Aarhus University Hospital, Norrebrogade 44, and Department of Clinical Physiology and Molecular Imaging (J.F.), Aarhus University Hospital and Department of Clinical Medicine, Aarhus University DK-8000 Aarhus, Denmark

4. NNF Center for Basic Metabolic Research (J.J.H.), DK-2200 Copenhagen, Denmark

5. Department of Biomedical Sciences, the Panum Institute, and Department of Biomedical Sciences (T.J.), the Panum Institute, University of Copenhagen, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark

6. Department of Pediatrics (S.R.), Aarhus University Hospital, Brendstrupgaardsvej 100, DK-8200 Aarhus N, Denmark

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/98/4/E664/9049382/jcemE664.pdf

Reference36 articles.

1. The physiology of glucagon-like peptide 1;Holst;Physiol Rev,2007

2. Incretin-based therapies in the management of type 2 diabetes: rationale and reality in a managed care setting;Garber;Am J Manag Care,2010

3. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials;Vilsboll;BMJ,2012

4. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor;Bullock;Endocrinology,1996

5. GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting;Körner;J Nucl Med,2007

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon-like peptide-1 (GLP-1) receptor agonists for weight management: A review for the gynecologic oncologist;Gynecologic Oncology;2024-11

2. Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction;Heart Failure Reviews;2024-09-13

3. The influence of insulin and incretin-based therapies on renal tubular transport;Journal of Nephrology;2024-08-21

4. Incretin-based therapy: a new horizon in diabetes management;Journal of Diabetes & Metabolic Disorders;2024-08-17

5. Natriuretic peptide system in hypertension: Current understandings of its regulation, targeted therapies and future challenges;European Journal of Pharmacology;2024-08